Steve Lee

OverviewAI-generated summary

Steve Lee's research has focused on cancer immunology, particularly in the context of head and neck squamous cell carcinoma. His work has investigated the role of immune cells, such as natural killer (NK) cells and dendritic cells, in response to cancer treatments like cetuximab. Lee has explored how these immune cells can be activated to trigger tumor antigen-specific T-cell immunity. His research has also examined the impact of specific immune cell populations, such as CTLA-4+ regulatory T cells, on treatment outcomes, noting their correlation with poor prognosis by suppressing NK cell cytotoxicity in cetuximab-treated head and neck cancer patients.

Beyond cancer research, Lee's publications include work on the validity of diagnostic criteria for attention-deficit/hyperactivity disorder in young children and the impact of management standards on work-related stress. He has also contributed to research on the therapeutic potential of mesenchymal stem cells in improving left ventricular function after myocardial infarction and has been involved in guidelines for the perioperative management of antirheumatic medications in patients undergoing joint arthroplasty. His scholarship metrics include an h-index of 35, with approximately 4,976 citations across 190 publications, and he is recognized as a highly cited researcher. Lee leads a research group and has collaborated with Shiv Srivastava on multiple publications.

Metrics

• h-index: 35
• Publications: 190
• Citations: 4,976